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Reconstructing Mayaro virus circulation in French
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Characterizing the circulation of Mayaro virus (MAYV), an emerging arbovirus threat, is
essential for risk assessment but challenging due to cross-reactivity with other alphaviruses
such as chikungunya virus (CHIKV). Here, we develop an analytical framework to jointly
assess MAYV epidemiology and the extent of cross-reactivity with CHIKV from serological
data collected throughout French Guiana (N= 2697). We find strong evidence of an
important sylvatic cycle for MAYV with most infections occurring near the natural reservoir
in rural areas and in individuals more likely to go to the forest (i.e., adult males) and with
seroprevalences of up to 18% in some areas. These findings highlight the need to strengthen
MAYV surveillance in the region and showcase how modeling can improve interpretation of
cross-reacting assays.
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Arboviruses constitute an important and evolving threat forpublic health. Mayaro virus (MAYV), an alphavirus oftencited as a likely candidate for the next major arbovirus
emergence1–4, is mainly transmitted by forest-dwelling Haema-
gogus mosquitoes to nonhuman primates and other mammalian
reservoirs and results in symptoms similar to those of dengue or
chikungunya5. Practices such as deforestation and human activ-
ities in forested regions6 increase the risk that MAYV will move
from a sylvatic cycle (i.e., circulates in an animal reservoir but
with only sporadic human infections) to a domestic cycle (i.e.,
self-sustaining transmission in humans) with important con-
sequences for public health. Active circulation has been con-
firmed in various areas including urban settings in Caribbean
area, South and Central America7–10, but surprisingly little is
known about its circulation in human populations.
Seroprevalence studies that quantify the proportion of the
population with antibodies against MAYV can help address such
knowledge gap in the level of circulation and spatial extent11 and
support risk assessment of this emerging pathogen. However,
following the widescale circulation of CHIKV in the Americas
since 2013, the evaluation of MAYV infection is greatly compli-
cated by serological cross-reactivity where CHIKV infected
individuals may experience a rise in MAYV antibody measures,
even if they have not been infected by MAYV. This problem of
cross-reactivity hampers serological studies across many different
pathogens12.
Here, we demonstrate that by jointly analyzing serological
results for both MAYV and CHIKV alongside data on the age and
location of participants, we can simultaneously reconstruct the
history of circulation of the viruses and the extent of cross-
reactivity. We apply our approach to MAYV and CHIKV in
French Guiana, a territory that has seen a CHIKV epidemic
between February 2014 and October 201513–15, as well as docu-
mented MAYV cases16,17. We randomly collected 2697
population-representative serum samples from all age-groups
from throughout French Guiana18 (Methods and Supplementary
Table 1). For each serum sample, we measured antibody
responses to both MAYV and CHIKV using a multiplexed
microsphere-based IgG immunoassay (MIA) that returned a
relative fluorescence intensity (RFI) for each pathogen19 (see
Methods section).
Results
Serology of MAYV and CHIKV. We find that almost all parti-
cipants with a MAYV RFI signal also exhibit a signal for CHIKV
(Fig. 1a). In the absence of a good understanding of the antibody
response following exposure and of cross-reactivity, we cannot
reliably estimate the proportion of participants historically
infected by MAYV from such laboratory results alone. If an
increase in MAYV RFI was solely due to cross-reactivity with
CHIKV, MAYV RFI should be roughly proportional to CHIKV
RFI in each region of French Guiana. However, we observe
important differences between regions (Fig. 1b). For example,
while the average MAYV RFI is much lower than the average
CHIKV RFI in Cayenne, it is higher in High Oyapock among
participants aged >20 years old (Fig. 1b). We hypothesize that the
true level of circulation of each virus and the level of cross-
reactivity can be identified if we integrate in our analysis the fact
that individuals with shared characteristics—age, region, sex,
housing, and income—tend to have correlated risks of historic
infection. Our approach jointly estimates the location-specific
annual force of infection (FOI, per capita rate at which a sus-
ceptible individual gets infected) for MAYV and CHIKV modu-
lated by pathogen-specific socio-demographic factors, and how
RFIs change to both the infecting and non-infecting virus
following infection (see Methods). In a simulation study, we find
that our approach is able to reliably estimate model parameters
and reconstruct viral circulation histories (See Supplementary
Tables 2 and 3).
Using this integrative analytical framework, we estimate that
MAYV RFI increases on the log scale by 2.2 (95% credible
interval (CrI): 2.1 –2.3) for an individual historically infected with
MAYV and by 0.22 (95% CrI: 0.20–0.23) after a CHIKV infection
while CHIKV RFI increases by 1.05 (95% CrI: 1.01–1.1) after a
MAYV infection and by 3.64 (95% CrI: 3.60–3.67) after a CHIKV
infection (Tab S4).
Assessing the history of virus circulation. In addition to cross-
reactivity, our model assesses the history of circulation and
infection risk factors for each virus. For MAYV, our best fitting
model (see Methods section Alternative models of virus circula-
tion and Supplementary Tables 6 and 7) assumes that the force of
infection for MAYV has remained stable over time, with
important regional variations (Fig. 2a). At any point in time,
we find that males are 1.9 (95% CrI: 1.3–2.7) times as likely to be
infected by MAYV than females, and adults are 5.1 (95% CrI:
2.2–10.5) times as likely to be infected than children (Fig. 2b).
Living in a carbet (typical Native American cabin without
walls) is a risk factor for MAYV infection (OR: 1.4, 95% CrI:
0.8–2.3). These estimates support the scenario of a sylvatic
transmission cycle for MAYV where most infections occur near
the natural reservoir in rural areas and where individuals more
likely to go to the forest (i.e., adult males) are also at higher risk of
infection.
For CHIKV, our best fitting model (see Methods section
Alternative models of virus circulation) correctly identifies that
the virus emerged only recently in French Guiana (Fig. 2a)20 and
predominantly circulated in the coastal and urbanized areas, as
well as the north western region of the territory. Contrasting with
MAYV, we find that females are more likely to be infected by
CHIKV than males (relative FOI is 1.2, 95% CrI: 1.0–1.4) and
children are as likely as adults to be infected (Fig. 2b). We find an
increased risk of CHIKV infection for individuals that spend
more time at home. We assessed whether this observation could
help explain the increased level of CHIKV infection among
women. In the survey, participants were asked the average time
they spend at home per day. We found that females were 1.38
(95% CrI: 1.13–1.69) times more likely than men to spend >16 h
per day at home. Spending time at home was also associated with
infection by CHIKV (OR, 95% CrI: 1.84 (1.41–2.40)), but not
significantly associated with MAYV infection (OR, 95% CrI: 1.30
(0.79–2.14)). These findings are consistent with a previous study
on CHIKV transmission in Bangladesh, which suggested that the
increased time women spend within and around their home
compared to men was responsible for an increased risk of
infection21. We also tested whether the differences between males
and females could be explained by differential boosting of the RFI
rather than different viral exposure levels. We ran the same model
using only males and only females. We found that the overall
prevalence was not modified by this additional assumption,
although we found a slightly larger mean boosting for females,
but larger individual variations for males (Supplementary
Table 8). There is a good adequacy between model predictions
and the data (Supplementary Figs. 1 and 2).
Model-based classification of infection. Once parameters char-
acterizing cross-reactivity and the force of infection have been
estimated, the model can be used to improve the interpretation of
serological assays and estimate the prevalence of infection. We
propose a model-based classification that derives for each possible
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-16516-x
2 NATURE COMMUNICATIONS |         (2020) 11:2842 | https://doi.org/10.1038/s41467-020-16516-x | www.nature.com/naturecommunications
value of the assays the probability of infection by MAYV and/or
CHIKV and classifies the result as infected if the estimated
probability of infection is above 50% (Fig. 3a). To validate the
model-based classification, 100 sera were selected for further
testing with anti-MAYV and anti-CHIKV microneutralization
tests (MNTs). Using the results from the MNTs as the gold
standard, we find that the model-based classification that uses
both RFI values performs substantially better than a classification
based on a simple optimized cut-off (Fig. 3b and Supplementary
Figs. 3 to 5).
a b
Fig. 1 Serology of MAYV and CHIKV in French Guiana. a MAYV and CHIKV relative fluorescence intensity (RFI) for the 2697 individuals included in
the study. b Map of French Guiana showing the location of samplings in 22 municipalities. Colors in the map indicate the seven geographical clusters.
Mean+/− SEM of the RFI stratified in 10-year age groups is shown for each region for MAYV (purple) and CHIKV (orange). Sample sizes for each age
class are given in Supplementary Table 4.
a
b
High Maroni
Low Oyapock High Oyapock Interior
Low Maroni Kourou Cayenne
Fig. 2 Model estimates of the determinants of infection. a Best model fit of the yearly probability of infection by MAYV (purple) and CHIKV (orange) of
an adult male in the different regions of French Guiana. Solid lines indicate the mean probability of infection and envelopes the 95% credible intervals.
b Relative risk of MAYV (purple) and CHIKV (orange) infection of individuals above 20 years old (relative to younger individuals), low income (relative to
high income), males (relative to females), living in a rural area (relative to an urban area), and living in a carbet (jungle housing) relative to other types of
habitations. Data are presented as the mean posterior with error bars denoting 95% credible intervals and the dashed line represents a relative risk of 1.
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Geographic distribution of seroprevalence. From the analysis of
transmission dynamics in the seven regions (Fig. 1b), we identi-
fied three larger regions (Maroni, Coast, high Oyapock/Interior)
that allowed us to divide the country into areas with distinct
epidemiological characteristics (Fig. 4a). The model-based clas-
sification was applied to data from each of these regions with
survey weights to derive representative estimates of ser-
oprevalence (Fig. 4b, c). We estimate that 20.3% (95% confidence
interval (CI): 18.5–22.1%) of the population was infected by
CHIKV, predominantly in the urban areas of the Coast and along
the Maroni river (Surinamese border) (Supplementary Fig. 6,
Supplementary Tables 9 and 10). This geographical distribution
of CHIKV appears similar to that previously found for Zika virus
(ZIKV)18. For both ZIKV and CHIKV, risk may be driven by the
repartition of Aedes aegypti, which may have reached almost all
inhabited areas but not the most remote villages. To date no study
has reported the presence of Ae.aegypti populations in the most
remote villages including Antecume Pata, Trois-Sauts and
Camopi villages22 where CHIKV seroprevalence rates varied from
0% to 1.42%. Furthermore, we estimate that 2.8% (95% CI:
2.2–3.4%) of the population was infected by MAYV (number of
seropositive individuals: 7263; 95% CI: 5764–8868 in a population
of 258,000). Highest seroprevalences were observed in sparsely
populated high Oyapock/Interior region (<1% of French Guiana
population), in agreement with previous studies which found
high MAYV seroprevalence in this region17. A majority of
infections inferred by the model (68%) came from the Maroni
region (Supplementary Fig. 7) where 10.0% (95% CI: 7.6–12.6%)
of the 49,169 inhabitants have been infected, and the annual
probability of infection is 0.45% (95% CrI: 0.35–0.56) – or 223
(95% CrI: 175–271) new infections per year (Supplementary
Table 11). These results show that MAYV transmission is higher
in remote forested areas of French Guiana and are consistent with
a sylvatic transmission of MAYV. We also found individuals with
historical infections of MAYV in the urban regions characterized
by low MAYV transmission. However, from our serological data,
it is not possible to determine whether these infections occurred
in these regions or during travel to other areas.
Had we inferred infections with a simple optimized cut-off,
cross-reactivity with CHIKV would have led to overestimating
the number of historical MAYV infections by almost 100%
(estimated number of infections: 13,838 compared to 7263 with
our model-based classification) and would have wrongly
indicated a recent, urban outbreak (Methods section Analysis
with a single cutoff). For MAYV, our best fitting model had a
constant risk of infection over time, with the individual risk of
infection increasing with age. As cross-sectional serological
surveys do not allow us to distinguish between variations in age
a b
Fig. 3 Classification of MAYV and CHIKV infections. a Graphical representation of the model-based classification that determines the infection status for
MAYV and CHIKV from the measured MAYV and CHIKV RFIs. For a classification with a simple cut-off, MAYV positive samples would lie on the right of
the dashed purple curve, and CHIKV positive samples above the orange curve. The boundaries were plotted considering a probability of MAYV infection of
5% and CHIKV infection of 20% (see Supplementary Fig. 4 for a sensitivity analysis where the infection probabilities are changed). b Contingency tables
comparing the simple cutoff and the model-based classifications using the seroneutralization assay (performed on 100 individuals) as a reference.
a b c
Fig. 4 Geographic distribution of MAYV and CHIKV seroprevalence. a Three regions of French Guiana with distinct epidemiological characteristics are
derived using the model estimates. b, MAYV and c, CHIKV seroprevalence estimated using the model-based classification (Maroni, n= 618; Coast, n=
1919, Interior, n= 160, Total, n= 2697). Points and error bars indicate the mean and 95% confidence intervals of the weighted seroprevalence,
respectively.
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and in time, this result could be equally explained by larger rates
of infection in the past and no difference in exposure between
children and adults. However, there is evidence of ongoing
MAYV transmission in French Guiana16, and MAYV is
transmitted by the forest-dwelling mosquito Haemagogus, which
is consistent with exposures in adult men who work in the forest.
To assess the risk of future MAYV emergence, it is important
to understand how the CHIKV outbreak affected the suscept-
ibility to MAYV. With our model-based classification, we found
only five individuals with evidence of historical infections by both
viruses. While this may be indicative of cross-immunity between
the two alphaviruses, it may also be due to the vectors occupying
different ecological niches. Serological assays alone are unable to
differentiate between these potential mechanisms. Future animal
challenge models may help in this context. Our results are specific
to the E2 antigens used in the assay. Future studies that use
different antigens would likely result in different estimates of
cross-reactivity.
The epidemiological interpretation of serological surveys is
often dogged by cross-reactivity between circulating pathogens23.
Our study shows how modeling techniques integrating multiple
data streams may overcome this issue, with important implica-
tions for the interpretation of pathogen serosurveys. Here, this
allowed us to determine the level of circulation of MAYV, which
is non-negligible in some parts of French Guiana. Our results
highlight the need to strengthen surveillance for MAYV in the
region so as to be able to quickly detect any substantial change in
MAYV circulation patterns that may be indicative of a rise to
emergence.
Methods
Study design and participants. A cross-sectional population-based serological
survey and household interviews was conducted in French Guiana between June
and October 2017. We reproduce here details on the random household selection,
sampling weights, interviews, ethical considerations that were described in Fla-
mand et al.18. The French Guianese territory is composed of 22 municipalities that
we broke down into seven geographical areas for the statistical analysis. The areas
and number of participants are given in Supplementary Table 1.
We estimated the sample size for this survey at 2500 persons distributed in the
French Guiana territory based on a 50% seroprevalence, 95% confidence, 90%
power and a cluster effect. To reach the desired sample size, a total of 1600
households were randomly selected for possible participation in the study from
household databases maintained by the Geographic information and knowledge
dissemination unit of the Regional environment, planning and housing agency and
the National Institute of Economic and Statistical Information (INSEE). A stratified
simple random sampling was adopted to select households allowing an over-
representation of the isolated and small municipalities. The global sampling
fraction of the households was 1:49 varying from 1:103 to 1:5 according to the
municipality.
We employ the following notation to describe the study design:
– i: one of the 22 strata (municipalities);
– Mi: number of primary sampling units (households) in the ith stratum,
i= 1, …, 22;
– Si: number of primary sampling units (households) selected from the ith
stratum, i= 1, …, 22;
– mi: number of primary sampling units (households) actually enrolled in the
study from the ith stratum, i= 1, …, 22;
– Pi: number of individuals living within the ith stratum, i= 1, …, 22
(census data);
– pi: number of individuals actually enrolled in the study from the ith stratum,
i= 1, …, 22;
We considered that, in each municipality i, the probability of selecting a
particular subject was equal to the probability of selecting his household and was
(mi/Mi), corresponding to a statistical weight equal to (1/mi/Mi)= (Mi/mi). This
statistical weight indicates the number of people in the population represented by
each subject in the sample.
We applied a post-stratification adjustment to each of these weights to arrive at
the final statistical weight for each subject. This adjustment helped us to weight the
age-sex groups within each municipality to match the distribution in the French
Guiana total population. Ten age groups ([2–5 years] [5–10], [10–15], [15–20],
[20–25], [25–35], [35–45], [45–55], [55–65], and ≥65 years) were defined within
male and female groups, and for each age-sex subgroup, we applied an adjustment
factor cijk to obtain a final statistical weight wijk= (Mi/mi)*cijk, where i, j, k are the
indices of municipalities, sex groups, and age groups, respectively.
Ethical considerations. Publicity and information about the survey was provided
through the media and contact with local and national authorities. Fieldworker
teams including investigators, nurses or medicine residents were trained to visit all
households, explain the project objectives, and, when allowed, collect participant’s
signatures in a free and informed consent form and carry out the interviews. All
members of selected households who were 2–75 years of age were invited to take
part in the study during a preliminary face-to-face interview. For all participants
under 18 years of age, one or two responsible adults signed the informed consent. A
specific educational-style comic book was designed for children 6 to 17 years of age
to explain, in an understandable way, the nature and objectives of the survey and
inform them about the voluntary nature of the participation of the study and their
rights to access and rectify their personal information. The study was recorded on
Clinicaltrials.gov (ID: NCT03210363) and approved by the “Sud-Ouest & Outre-
Mer IV” Ethical Research Committee (No.CPP17-007a/2017-A00514-49) and by
the French Data Protection Authority (No.DR-2017-324) responsible for ethical
issues and protection of individual data collection.
Blood sample collection. Blood samples were collected into 5 mL gold BD
Vacutainer SST II advance tubes with gel for serum separation (Becton-Dickinson,
USA). Immediately after puncture, samples were stored at 4 °C–8 °C until cen-
trifugation within 12 h. Sera were then frozen and stored at −20 °C until use at the
National Reference Center for arboviruses in Institut Pasteur in French Guiana.
Multiplex microsphere-based immunoassay. Collected sera were tested using an
in-house microsphere-based multiplex immunoassay (MIA) based on recombinant
antigens. The recombinant ectodomain of the CHIKV and MAYV envelope E2
glycoproteins were used for the capture of specific IgG antibodies, whereas a
recombinant human protein (O6-methylguanine DNA methyltransferase) was
used as control antigen in the assay. Distinct MagPlex microsphere sets (Luminex
Corp., Austin, TX) were, respectively, bound to viral and control proteins using the
amine coupling kit (Bio-Rad Laboratories, Hercules, CA) according to manu-
facturers’ instructions. The MIA procedure was performed as described previously
with minor modifications24. Briefly, microsphere mixtures were sequentially
incubated in the dark under constant shaking with a 1:400 dilution of serum
samples and 4 μg mL−1 anti-human IgG phycoerythrin-conjugated antibody
(Jackson Immunoresearch, West Grove, PA). After the final incubation, the median
fluorescence intensity (MFI) of each microsphere set was quantified using a
MagPix instrument (Bio-Rad Laboratories). For each sample, the CHIKV and
MAYV Relative Fluorescence Intensities (RFI) were calculated by dividing the MFI
signal measured for the CHIKV or MAYV microsphere sets by the MFI signal
obtained for the control microsphere set.
Seroneutralization. To validate the model-based classification, 100 sera were
selected for further testing with anti-MAYV and anti-CHIKV microneutralization
tests (MNTs). Briefly MNTs were conducted in serial 2-fold dilutions of heat
inactivated sera starting at 1:10 mixed in equal volume with 100 tissue culture
infectious dose 50 (TCID 50) of MAYV or CHIKV (French Guiana strains). After
incubation at 37 °C for 1 h, mixtures were transferred onto 96 well tissue culture
plates containing subconfluent Vero cells. Plates were incubated at 37 °C for 6 days
for MAYV and 5 days for CHIKV before lecture of cytopathic effects. The neu-
tralization titer is expressed as the reciprocal of the highest serum dilution at which
infection is blocked. A serum is considered positive for titer above 10. The indi-
viduals were selected as follows: 50 individuals from Cayenne (low MAYV ser-
oprevalence) and 50 individuals from Maroni and Oyapock (high MAYV
seroprevalence).
Urbanization level. Urbanization level was obtained from a land use classification
based on the proportion of households within a 1km-buffer (Rural: p < 50%;
Urban: p >= 50%).
Statistical model. We describe in this section the statistical model developed for
this study.
Notation. We consider an individual j. The infection status Ij indicates whether
individual j was infected by MAYV and/or CHIKV. The ensemble of all possible
infection statuses is I= {(1,0), (0,1), (0,0), (1,1)} where the first and second element
denotes whether an individual was infected by MAYV and CHIKV, respectively.
We denote tMj the value of the MAYV RFI for individual j (t
C
j for CHIKV). θ is the
parameter vector. Individual sociodemographic characteristics are denoted Xj.wj is
the sampling weight for individual j, indicating the number of people in the
population represented by individual j in the sample (see details in ref. 18).
φðxjμ; σÞ is the probability density function of a normal distribution of mean μ and
standard deviation σ.
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Hierarchical structure of the model. We start with the scenario where the
infection status is known and then move on to when it is unknown. We can break
down the probability of measured RFIs and infection status into two components:
P tMj ; t
C
j ; Ijjθ;Xj
 
¼ P tMj ; tCj jIj; θ;Xj
 
P Ijjθ;Xj
 
: ð1Þ
The first part represents the antibody dynamics model and the second part the
virus circulation model.
Antibody dynamics model. We model the serological response of an individual as
the result of infections by MAYV and/or CHIKV. Several mechanisms contribute
to the assay outcome: infection leads to a boost of the RFI for the infecting virus;
cross-reactivity may also translate into a rise of the RFI when an individual is
infected with another virus. We derive the four probabilities of measured RFIs
given the infection status:
1. If an individual has not been infected, the log RFIs are drawn from a normal
distribution centered around a background response (μM0 for MAYV and μ
C
0 for
CHIKV) with standard deviations εM and εC:
P tMj ; t
C
j jIj ¼ ð0; 0Þ; θ;Xj
 
¼ φ tMj jμM0 ; εM
 
´ φ tCj jμC0 ; εC
 
: ð2Þ
The standard deviations translate individual variations in the RFI.
2. If an individual has been infected by MAYV only, MAYV log RFI is drawn
from a normal distribution of mean μM0 þ μM with standard deviation εM Cross-
reactivity is modeled as an increase in CHIKV log RFI by a factor that is
proportional to MAYV RFI tMj after infection
P tMj ; t
C
j jIj ¼ ð1; 0Þ; θ;Xj
 
¼
φ tMj jμM0 þ μM; εM
 
´ φ tCj jμC0 þ μM!CtMj ; εC
  ð3Þ
where μM!C is the proportional multiplicative term.
3. If an individual has been infected by CHIKV only, we similarly model the
increase in CHIKV RFI and cross-reactivity by
P tMj ; t
C
j jIj ¼ ð0; 1Þ; θ;Xj
 
¼
φ tMj jμM0 þ μC!MtCj ; εM
 
´φ tCj jμC0 þ μC; εC
 
:
ð4Þ
4. If an individual has been infected by both MAYV and CHIKV, the response
is
P tMj ; t
C
j jIj ¼ ð1; 1Þ; θ;Xj
 
¼
φ tMj jμM0 þ μM ; εM
 
´ φ tCj jμC0 þ μC; εC
 
:
ð5Þ
We tested alternative antibody models: a model without cross-reactivity, a model
where cross-reactivity exists but does not induce a response proportional to the
infecting virus response, and a model where infection by both viruses leads to an
increase in RFI larger than the one observed after a single infection. This sensitivity
analysis is presented in section Model comparison and sensitivity analysis.
Virus circulation model. The analysis of age-specific seroprevalence profiles is key
to estimate historical patterns of viral circulation and the associated risk factors of
exposure. Methods known as serocatalytic models are commonly used to recon-
struct the annual force of infection (per capita rate at which susceptible individuals
are infected on a given year, FOI) from cross-sectional serological surveys. With λi
the FOI on year i, the probability to survive infection during year i for an individual
susceptible to infection at the start of year i is equal to exp(−λi). On year S, the
probability that individual j of age aj was ever infected is
Pj ¼ 1 exp 
Xaj
i¼0
λSi
 !
ð6Þ
We compare different competing models of virus circulation to explain the
observed seroprevalence. In particular, we consider models characterized by con-
stant circulation and by more irregular epidemics.
1. Constant model
In the constant model, the FOI λ is the same every year. The contribution to the
likelihood of infected individual j of age aj is
Pj ¼ 1 exp ajλ
 
: ð7Þ
2. Epidemic model
We consider for the epidemic model a single peak in the annual FOI. A
Gaussian model was assumed for the epidemic, in which the FOI on year i is given
by
λi ¼ α exp  i Tð Þ2
 
; ð8Þ
where α ¼ α=Pi exp  i Tð Þ2 . This model has two parameters: T is the year at
which the FOI is maximal, α is the total FOI.
Predictors of infection in the serocatalytic models. In addition to temporal
variations of the FOI, we also explore the role of age, housing, income, sex and
living in a particular region as predictors of the risk of infection by MAYV and
CHIKV. We included these predictors in the model by introducing multiplicative
factors to the FOI. The vector of sociodemographic characteristics of individual j is
Xj ¼ ðagej; regioinj; environmentj; sexj; housingj; incomejÞ:
The total cumulative strengths of MAYV and CHIKV infection for individual j
are
ΛMj ¼
Xagej
i¼0
FMðXj; iÞ ´ λM2017i ð9Þ
ΛCj ¼
Xagej
i¼0
FC Xj; i
 
´ λC2017i ð10Þ
where λM2017i and λ
C
2017i are terms characterizing the annual variations of the FOI
and the multiplicative factors are given by (for MAYV)
FMðXj; iÞ ¼ fM1 ðagej  iÞfM2 ðregionjÞfM3
ðenvironmentjÞfM4 ðsexjÞfM5 ðhousingjÞfM6 ðincomejÞ
where fM1 ðagej  iÞ is the relative susceptibility to MAYV infections of individuals
at age agej−i compared with adults (children are defined as under 20 years old).
fM2 ðregionjÞ,fM3 ðenvironmentjÞ; fM4 ðsexjÞ,fM5 ðhousingjÞ,fM6 ðincomejÞ are,
respectively, the relative susceptibility of:
– inhabitants of regionj (High Maroni, Low Maroni, Kourou, Cayenne, High
Oyapock, Low Oyapock, Interior) compared with inhabitants of High Maroni
– inhabitants of environmentj (urban or rural) areas compared with inhabitants
of urban areas
– sexj (males or females) compared with males
– people living in housingj (carbet or other housings) compared with people
living in carbets
– people earning incomej (high or low income) compared to a low income.
The terms λM2017i and λ
C
2017i therefore represent the FOI on year 2017-i of a
male adult, with low income, living in a carbet in urban part of High Maroni.
In the context of the model that considers two circulating viruses and individual
specific risks of infection, we extend Eq. (6) and obtain the infection probabilities:
P Ij ¼ ð0; 0Þjθ;Xj
 
¼ eΛMj eΛCj
P Ij ¼ ð1; 0Þjθ;Xj
 
¼ 1 eΛMj
 
eΛ
C
j
P Ij ¼ ð0; 1Þjθ;Xj
 
¼ eΛMj 1 eΛCj
 
P Ij ¼ ð1; 1Þjθ;Xj
 
¼ 1 eΛMj
 
1 eΛCj
 
ð11Þ
Regional differences in exposures were included as a multiplicative factor in
the FOI but we assumed no spatial difference in the timing of epidemics. The
CHIKV outbreak started in the region of Kourou and then spread to the rest of
the territory, but this is a pattern that cannot be reconstructed from the
serological survey. To detect spatial variation of T, significant differences in the
seroprevalence of infants between the different regions would be required.
However, only 15 of them are 2 years old and 9 are 3 years old over the whole
territory. Among the children under 5 years old, only 12% (5/43) were found to
having been infected by CHIKV. Therefore, we lacked of statistical power to
identify the spatial spread of CHIKV.
Inference: In practice the infection status is unknown and only the RFIs are
observed. The contribution to the likelihood of individual j has to be summed over
all possible infection statuses and is
Lj ¼ P tMj ; tCj jθ;Xj
 
¼
P
Ik2I
P tMj ; t
C
j jIj ¼ Ik ; θ;Xj
 
PðIj ¼ Ik jθ;XjÞ
ð12Þ
where the first part of the sum was derived in Eqs. (2–5) and the second part in
Eq. (11).
Priors. Flat priors where chosen for most of the antibody model and viral circu-
lation parameters. The prior distributions are Uniform (0,5) for μM,μ C, μM→C,
μC→M, εM, εC, the FOI λ (constant model), α (Epidemic model). The cross-reactive
terms were allowed to vary to be either greater or smaller than the terms of the
infecting pathogen response. For the Gaussian model of epidemics, the parameter
of the peak position T is Uniform (1967, 2017). Informative priors were chosen
forμM0 (Normal (0,1)) and μ
C
0 (Normal (−0.4,1)). For the parameters characterizing
the relative risk of infections, f1 to f6, a log normal distribution of mean 0 and
variance 3 was chosen. This ensures that the groups chosen as reference have no
influence on the inferred relative risks (e.g., the prior of the ratio male/female is the
same as the prior female/male)25.
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Estimation using MCMC. Parameters were estimated using a Markov Chain
Monte Carlo (MCMC) algorithm implemented in the rstan package (version
2.19.2)26. The No-U-Turn sampler variant of Hamiltonian Monte Carlo was used
to update parameters. Four independent chains of 20000 iterations were ran; the
first 10000 iterations correspond to a burnin period.
Ninety-five percent credible intervals were defined as the 2.5% and 97.5%
percentiles of the posterior distributions. Parameter estimates for the model for
antibody dynamics are given in Supplementary Table 5. Models were compared
using the deviance information criterion (DIC). A smaller DIC indicates a better fit.
Models with DIC under the smallest DIC+5 were considered equally adequate
explanations of the data.
Selection of explanatory variables. Predictors were chosen as follows. We first
ran the model without considering the predictors in the force of infection. We used
a univariate logistic regression model to predict MAYV and/or CHIKV infections
determined by the model with socio-demographic or environmental variables.
Variables with an odds ratio significantly different than 1 were added as an
explanatory variable in the FOI model.
Model-based classification of MAYV and CHIKV infections. Conditional on
parameter value θ, the probability that individual j has an infection profile Ij is
given by
P IjjtMj ; tCj ; θ;Xj
 
¼
P tMj ; t
C
j jIj; θ;Xj
 
PðIjjθ;XjÞP
Ik2I
P tM; tCjIkθ;Xj
 
PðIk jθ;XjÞ
ð13Þ
where the infection probabilities are given in Eq. (11) and the denominator is a
sum over the four infection profiles. The expected infection status for individual j is
obtained by averaging the probability (Eq. 13) over the posterior distribution of
parametersp θjtMj ; tCj ;Xj
 
P IjjtMj ; tCj ;Xj
 
¼
Z
P IjjtMj ; tCj ; θ;Xj
 
p θjtMj ; tCj ;Xj
 
dθ
which is obtained in practice by summing over the values of θ over the MCMC
chain
P IjjtMj ; tCj ;Xj
 
¼ 1
M
XM
s¼1
P IjjtMj ; tCj ; θs;Xj
 
where M is the chain length and θs the parameter vector with index s in the chain.
Infection status of an individual is assessed by taking the most likely expected
infection status. We plotted in Fig. 3a the areas of infection profiles fixing infection
probabilities PM ¼ 1 eΛMj ¼ 0:05 and PC ¼ 1 eΛCj ¼ 0:2 for all individuals.
Taking for example Ij= (1,0), Eq. (13) becomes
P Ij ¼ ð1; 0ÞjtMj ; tCj ; θ;Xj
 
¼
P tMj ;t
C
j jIj ;θ;Xjð ÞPMð1PCÞP
Ik2I
P tM ;tC jIkθ;Xjð ÞPðIk jθ;XjÞ :
To evaluate the relative importance of PM and PC in the determination of the
infection profile, we plotted the boundaries for various values of the infection
probability (Supplementary Fig. 3). We show that values of PM and PC have little
impact on the likely infection profile which is therefore mostly determined by the
RFI values.
The number of infected individuals. The total number of infections was obtained
from the individual model-based predictions of infections weighted by the sam-
pling weights. The 95% confidence intervals of the number of infections were
estimated from 10,000 bootstrap resamples where each individual is the resampling
unit and where each individual weight was renormalized to keep the total weight
unchanged (representing the total number of inhabitants in French Guiana or
within a subregion of interest).
The annual probability of MAYV infection was estimated with the formulaP
j wjP
M
j annual infectionð ÞP
j wj
where PMj annual infectionð Þ ¼ PMnever infectedj ´P
Minfected this year
j is given by
PMj annual infectionð Þ ¼ eΛ
M
j 1 exp FM Xj;1
 
´ λM2017
  
Annual infection probabilities for MAYV are reported in Supplementary
Table 11.
Choice of the threshold value in the simple cutoff classification. The single
cutoff classification relies on comparing the RFI with a threshold value, indepen-
dently of the RFI for the other virus. We plotted the histograms of MAYV (Sup-
plementary Fig. 5a) and CHIKV RFIs (Supplementary Fig. 5b), together with the
value of the chosen single threshold cutoff. This value was chosen so as to
maximize the sum of the sensitivity and specificity (Supplementary Fig. 5c, d),
which were obtained by considering the seroneutralization as the reference
diagnostic.
Analysis with a simple cutoff. To assess the importance of taking into account
cross-reactivity in the understanding of the epidemiology of CHIKV and MAYV,
we fitted standard serocatalytic models to data, considering seroprevalence based
on the simple cutoff instead of the quantitative values of the RFI.
As opposed to the model with cross-reactivity, here, a circulation model in
which French Guiana experienced a recent MAYV outbreak was as adequate as a
model of constant circulation (DIC= 3599 and DIC= 3600); age (OR: 0.8, 95%
CrI: 0.4–1.3) and sex were no longer significant risk factors for MAYV infection
(OR: 1.2, 95% CrI: 0.9–1.6).
The reason for these discrepancies between the model-based classification and
the simple cutoff is that MAYV and CHIKV have contrasting risk factors for
infection: males (respectively, females) are more exposed to MAYV (respectively,
CHIKV). Many children and women infected by CHIKV in the urban areas are
tested positive for MAYV with the simple cutoff, therefore leading to estimate that
MAYV was recent and urban in French Guiana.
Model adequacy. We assessed model adequacy by simulating 100 surveys in a
population with the same characteristics (age, sex…) as in the dataset and with
parameters drawn from the posterior distribution.
The simulated surveys could reproduce the observed age profile of the RFI
distribution in the different regions except in High Oyapock (Supplementary
Fig. 1). For this region, we explored if a model combining constant MAYV
circulation along with a MAYV outbreak could improve the fit. While such model
improved the fit for MAYV RFIs, it worsened it for CHIKV RFIs (Supplementary
Fig. 2), and no overall improvement in terms of DIC was observed (Supplementary
Table 6).
In addition, we tested the ability of our approach to identify the correct
epidemiological (constant force of infection vs. epidemic transmission), we
simulated serological surveys for each of these scenarii. Both surveys had 500
individuals with age randomly drawn between 1 and 70. In the first simulation,
we assumed a constant annual probability of infection of 0.01. In the second, we
assumed an outbreak that happened in 1980 and infected 20% of the population.
We fitted the epidemic and constant model on the two datasets. The DIC shows
we are able to identify the correct scenario: we obtained a difference of DIC of
35 for the constant model survey and of 42 for the epidemic model survey. We
also estimated the posterior distribution of the parameters. The probability of
infection in the first model is 0.94% (95% CrI: 0.78–1.11%) (real value= 1%).
For the outbreak model we found T to be 1979 (95% CrI: 1977–1981) and the
probability of infection is 22% (95% CrI: 16–28%).
Evaluation of the statistical framework. We also performed a simulation study to
evaluate the performance of our statistical framework. One survey was simulated
with parameters equal to the posterior mean we estimated in our analysis. We ran
our MCMC algorithm on these simulated data. Parameters of antibody model
dynamics (Supplementary Table 2) and model-based classification of infections for
the number of infected by MAYV and/or CHIKV in the simulation (Supplemen-
tary Table 3) were well estimated.
Model comparison and sensitivity analysis. To ensure that our main conclusions
were robust to modeling assumptions, we explored and compared different model
variants in a sensitivity analysis. We considered variations of the model presented
in this study, by
• Considering other models of antibody response after infection
• Assuming different models of virus circulation
• Removing the predictors from the model of virus circulation
• Different responses for males and females.
Alternative antibody models. We considered three alternative models for the
antibody response to infection. In a first model we assumed that there is no
cross-reactivity. Equations (3, 4) of the antibody dynamics model are in this case
replaced by:
P tMj ; t
C
j jIj ¼ ð1; 0Þ; θ;Xj
 
¼
φ

tMj jμM0 þ μM; εM

´ φ tCj jμC0 ; εC
  ð14Þ
P tMj ; t
C
j jIj ¼ ð0; 1Þ; θ;Xj
 
¼ φ tMj jμM0 ; εM
 
´ φ tCj jμC0 þ μC; εC
 
ð15Þ
In a second model, we included cross-reactivity terms that are not proportional
to the response of the other virus, and for which the Eqs. (3) and (4) in the
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antibody dynamics model are replaced by
P tMj ; t
C
j jIj ¼ ð1; 0Þ; θ;Xj
 
¼
φ tMj jμM0 þ μM; εM
 
´ φ tCj jμC0 þ μM!C; εC
  ð16Þ
P tMj ; t
C
j jIj ¼ ð0; 1Þ; θ;Xj
 
¼
φ tMj jμM0 þ μC!M;εM
 
´φ tCj jμC0 þ μC; εC
  ð17Þ
In a third model, we considered that infection by both viruses leads to a boosting of
the RFI that includes direct response and cross-reactivity. Equation (5) becomes
P tMj ; t
C
j jIj ¼ ð1; 1Þ; θ;Xj
 
¼
φ tMj jμM0 þ μM þ μC!MtCj ; εM
 
´φ tCj jμC0 þ μC þ μM!CtMj ; εC
  ð18Þ
Values of the DIC show strong support for the model with proportional increase of
the response due to cross- reactivity (DIC= 10,343, vs. 11,832, 10,531, and 10,364
for the absence of cross-reactivity, the other cross-reactivity model, and the
increased boosting model, respectively).
Alternative models of virus circulation. We tested four combinations of virus
circulation models where (i) MAYV is constant and CHIKV is epidemic, (ii) both
MAYV and CHIKV are epidemic, (iii) both MAYV and CHIKV are constant, (iii)
MAYV is epidemic and CHIKV circulation is constant. DICs of the different
models are shown in Supplementary Table 6. The best fitting model was the one
where the FOI was constant for MAYV but epidemic for CHIKV; this scenario was
therefore considered as our baseline model.
Given model adequacy (Supplementary Fig. 1), we also considered a model
where MAYV circulation in high Oyapock was characterized by both constant
circulation and an epidemic (Supplementary Fig. 2). This model improved the fit
for MAYV RFIs but gave worse results for CHIKV RFIs. No overall improvement
in terms of DIC was observed (Supplementary Table 6).
Alternative models for risk factors of infection. We fitted the data by removing
one predictor of the FOI at a time. DIC indicates higher support for the model with
all the predictors (Supplementary Table 7).
Different responses for males and females. To test the hypothesis that males
and females had different boosting, we estimated the model parameters on the
subsets of males and females, respectively. We obtained small differences in the
model estimates. The MAYV response for females was estimated to be 2.39 (95%
CrI: 2.23–2.58) compared to 2.04 (95% CrI: 1.9–2.18) for males. Similarly females
had a slightly higher CHIKV response of 3.71 (95% CrI: 3.65–3.75) vs. 3.55 (95%
CrI: 3.48–3.62) for males. However we found larger individual variation among
males compared to females (parameters εM and εC). The mean posterior of εM was
0.51 (95% CrI: 0.50–0.53) for females and 0.54 (95% CrI: 0.52–0.56) for males. The
mean posterior of εC was 0.39 (95% CrI: 0.38–0.41) for females and 0.45 (95% CrI:
0.43–0.47) for males (see Supplementary Table 8). Cross-reactivity parameters were
estimated to be similar. Overall, the results on prevalence were similar to the
baseline where we did not account for differential boosting. The total number of
infected individuals was 73 males and 58 females for MAYV (total= 131 compared
to 133 with the baseline model) and 192 males and 350 females for CHIKV (total
= 542, which is the same as the baseline model).
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The following data is available in a format that maintains anonymity of survey participants
from the GitHub link at https://github.com/nathoze/Mayaro. For each individual: age group
(10-year classes), MAYV RFI, CHIKV RFI, region (Maroni, Coast, Interior and High
Oyapock), sex, income (high or low), environment (urban or rural), and sampling weight.
Code availability
Code is available from the GitHub link at https://github.com/nathoze/Mayaro.
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